• 1
    Isaacson PG, Nathwani BN, Piris MA et al. Nodal marginal zone B-cell lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press, 2001; 16.
  • 2
    Lymphoma Study Group of Japanese Pathologists. The World Health Organization classification of malignant lymphoma in Japan: Incidence of recently recognized entities. Pathol Int 2000; 50: 696702.
  • 3
    Isaacson PG, Mûller-Hermelink HK, Piris MA et al. Extranodal marginal zone B-cell lymphoma of mucosa associated lymphoid tissue (MALT lymphoma). In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press, 2001; 15760.
  • 4
    Campo E, Miquel R, Krenacs L, Sorbara L, Raffeld M, Jaffe ES. Primary modal marginal zone lymphomas of splenic and MALT type. Am J Surg Pathol 1999; 23: 5968.
  • 5
    Nathwani BN, Drachenberg MR, Hernanzez AM, Levine AM, Sheibani K. Nodal monocytoid B-cell lymphoma (nodal marginal-zone B-cell lymphoma). Semin Hematol 1999; 36: 12838.
  • 6
    Berger F, Felman P, Thieblemont C et al. Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients. Blood 2000; 95: 19506.
  • 7
    Conconi A, Bertoni F, Pedrinis E et al. Nodal marginal zone B-cell lymphomas may arise from different subsets of marginal zone B lymphocytes. Blood 2001; 98: 7816.
  • 8
    Taddesse-Heath L, Pittaluga S, Sorbara L, Bussey M, Raffeld M, Jaffe ES. Nodal marginal zone B-cell lymphoma in young adults. Am J Surg Pathol 2003; 27: 52231.
  • 9
    Camacho FI, Algara P, Mollejo M et al. Nodal marginal zone B-cell lymphoma: a heterogenous tumor. A comprehensive analysis of a series of 27 cases. Am J Surg Pathol 2003; 27: 76271.
  • 10
    Kojima M, Nakamura S, Motoori T et al. Primary marginal zone B-cell lymphoma of the lymph node resembling plasmacytoma arising from a plasma cell variant of Castleman's disease. A clinicopathological and immunohistochemical study of seven patients. APMIS 2002; 110: 87580.
  • 11
    Traverse-Glehen A, Felman P, Gallet-Bauchu E et al. A clinicopathological study of nodal marginal zone B-cell lymphoma: a report of 21 cases. Histopathology 2006; 48: 16273.
  • 12
    Feller AC, Diebold J. Histopathology of Nodal and Extranodal Non-Hodgkin's Lymphomas. Berlin: Springer, 2004.
  • 13
    Kojima M, Nakamura S, Murase T et al. Follicular colonization of nodal marginal zone B-cell lymphoma resembling follicular lymphoma: report of six cases. Int J Surg Pathol 2005; 13: 738.
  • 14
    Karube K, Ohshima K, Tsuchiya T et al. A ‘floral’ variant of nodal marginal zone lymphoma. Hum Pathol 2005; 36: 2026.
  • 15
    Diebold J, Tourneau AL, Comperat E, Molina T, Audouín J. Primary splenic and nodal marginal zone lymphoma. J Clin Exp Hematopathol 2005; 45: 114.
  • 16
    Nathwani BN, Anderson JR, Armitage JO et al. Marginal zone B-cell lymphoma: a clinical comparison of nodal and mucosa-associated lymphoid tissue types. J Clin Oncol 1999; 17: 248692.
  • 17
    The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 1997; 89: 390918.
  • 18
    Wan JH, Trainor KJ, Brisco MJ, Morley AA. Monoclonality in B cell lymphoma detected in paraffin wax embedded sections using the polymerase chain reaction. J Clin Pathol 1990; 43: 88890.
  • 19
    Wang T, Lasota J, Hanau CA, Miettinen M. Bcl-2 oncoprotein is widespread in lymphoid tissue and lymphoma but its different expression in benign versus malignant follicles and monocytoid B-cell proliferation is of diagnostic value. APMIS 1995; 103: 65562.
  • 20
    Lai R, Arber DA, Chang KL, Wilson CS, Weiss LM. Frequency of bcl-2 expression in non-Hodgkin's lymphoma: a study of 778 cases with comparison of marginal zone lymphoma and monocytoid B-cell hyperplasia. Mod Pathol 1998; 11: 8649.
  • 21
    Lai R, Weiss LM, Chang KL, Arber DA. Frequency of CD43 expression in non-Hodgkin lymphoma: A survey of 742 cases and further characterization of rare CD43+ follicular lymphomas. Am J Clin Pathol 1999; 111: 48894.
  • 22
    Inagaki H, Chan JK, Ng JWM et al. Primary thymic ectranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type exhibits distinctive clinicopathological and molecular features. Am J Pathol 2002; 160: 143543.
  • 23
    Kaplan EL, Meier P. Non-parametric estimation from incomplete observation. Am J Stat Assoc 1958; 53: 45781.
  • 24
    Peto PE, Pike MC, Armitage P et al. Design and analysis of randomized clinical trails requiring prolonged observation of each patients. Br J Cancer 1977; 35: 139.
  • 25
    The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993; 329: 98794.
  • 26
    Allzadeh AA, Elsen MB, Davis RE et al. Distinct type of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 40: 350311.
  • 27
    Hans CP, Weisenburger DD, Greiner TC et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004; 103: 27582.